台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    90.5
  • 漲跌
    ▼0.3
  • 漲幅
    -0.33%
  • 成交量
    135
  • 產業
    上市 生技醫療類股
  • 330人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
佳醫 (4104)籌碼相關-富邦-民雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-民雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2021/01/221054.7000.0054.60102184.59%
2021/01/181055.5000.0055.60102074.82%
2020/12/0700.00156.9057.00-1193-0.52%
2020/11/1800.00357.1057.00-3221-1.36%
2020/11/06356.8000.0056.7032501.20%
2020/10/13256.0000.0056.1023890.51%
2020/09/2500.00154.8055.10-1502-0.20%
2020/08/2700.00156.8056.70-1612-0.16%
2020/07/31457.95358.0757.7017190.14%
2020/07/2900.00259.5059.70-2694-0.29%
2020/07/14161.902062.0062.00-19623-3.05%
2020/07/1300.002061.5561.90-20616-3.25%
2020/07/073261.253261.5261.6005710.00%
2020/07/0600.00259.8060.00-2538-0.37%
2020/07/01159.4000.0059.5015250.19%
2020/06/29159.7000.0059.4015200.19%
2020/06/231058.1500.0058.10105021.99%
2020/06/1800.002659.6159.60-26484-5.37%
2020/06/17658.8000.0058.8064661.29%
2020/06/1500.00158.0058.00-1474-0.21%
2020/06/11458.1000.0057.2044670.86%
2020/06/0900.00258.2058.30-2463-0.43%
2020/06/0400.001457.5957.70-14471-2.97%
2020/06/03258.00558.0057.80-3469-0.64%
2020/06/02157.7000.0057.9014650.21%
2020/06/0100.00557.8057.70-5461-1.08%
2020/05/2900.00656.2756.20-6448-1.34%
2020/05/26357.6300.0057.1034380.68%
2020/05/25257.702057.4358.00-18426-4.22%
2020/05/22457.15557.3857.00-1406-0.25%
2020/05/15254.8000.0054.9023580.56%
2020/05/0700.00354.6356.00-3331-0.90%
2020/05/06454.63254.2054.0023060.65%
2020/04/2700.000.553.4053.40-0.5307-0.17%
2020/04/220.852.5000.0052.500.83150.24%
2020/04/211252.3100.0051.70123143.82%
2020/04/17152.6000.0052.6013120.32%
2020/03/2500.008.350.1549.85-8.3306-2.71%
2020/03/202048.8900.0048.80203046.56%
2020/03/1900.002047.6946.40-20302-6.62%
2020/03/181049.70249.8049.6082902.75%
2020/03/161051.5000.0050.60102823.54%
2020/03/13149.7000.0050.6012770.36%
2020/03/04552.5000.0052.7052492.01%
2020/02/2700.00453.2052.60-4253-1.58%
2020/02/1700.000.252.7052.30-0.2255-0.06%
2020/01/2000.00453.4053.50-4258-1.55%
2020/01/090.252.9000.0052.900.22420.08%
2019/12/2500.00253.8053.80-2231-0.86%
2019/12/24154.1000.0054.1012360.42%
2019/12/23153.8000.0053.8012330.43%
2019/11/2900.00155.0053.90-1235-0.43%
2019/11/08152.4000.0052.6012460.41%
2019/10/3000.001053.4054.00-10249-4.01%
2019/10/17253.3000.0053.3023430.58%
2019/10/0200.00152.0052.20-1403-0.25%
2019/08/2900.00153.0053.30-1408-0.24%
2019/08/27153.0000.0053.0014060.25%
2019/08/1600.000.650.9050.90-0.6382-0.16%
2019/08/1400.00150.5050.60-1379-0.26%
2019/07/23154.1000.0054.1013030.33%
2019/07/181054.9000.0054.80102553.92%
2019/07/0900.000.152.9052.90-0.1193-0.05%
2019/05/2800.00150.6050.80-1174-0.57%
2019/05/271150.2300.0050.70111736.35%
2019/02/26148.3000.0048.3011610.62%
2019/01/07247.0000.0046.7521281.56%
2019/01/04846.7800.0046.7081296.18%
2019/01/03446.1500.0045.9041263.16%
2018/12/03246.1500.0045.9021641.21%
2018/11/29445.5500.0045.5041662.40%
2018/11/122045.4600.0045.202017211.59%
2018/08/1400.00148.0048.00-1455-0.22%
2018/08/081050.50150.6050.5094631.94%
2018/07/1200.00150.6051.00-1792-0.13%
2018/07/06148.0000.0048.6517780.13%
2018/06/2800.00150.2050.50-1867-0.12%
2018/06/2600.00150.6050.60-1914-0.11%
2018/06/13352.90251.9051.9019670.10%
2018/06/12150.9000.0050.7019180.11%
2018/05/07351.83352.4051.8007020.00%
2018/05/04348.47350.5050.5005980.00%
2018/05/03249.808.350.0049.20-6.3555-1.13%
2018/05/0200.00549.3549.20-5521-0.96%
2018/04/2700.00548.0048.20-5505-0.99%
2018/04/261048.80448.8047.8065051.19%
2018/04/25147.9000.0048.5014960.20%
2018/04/2300.00150.0050.00-1478-0.21%
2018/04/09350.13349.8849.6504260.00%
2018/04/0300.00148.2048.20-1373-0.27%
2018/03/2900.00148.4048.35-1327-0.31%
2018/03/2700.00147.2046.75-1266-0.37%
2018/03/22446.7000.0045.9042371.69%
2018/03/2000.00146.5546.55-1225-0.44%
2018/02/09143.9000.0043.9512860.35%
2018/02/0100.00146.0045.85-1278-0.36%
2018/01/1500.00145.7046.15-1247-0.40%
2018/01/1000.00145.2045.30-1222-0.45%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音